Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Koninklijke Philips N.V.    PHIA   NL0000009538

KONINKLIJKE PHILIPS N.V.

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Koninklijke Philips N : Philips Targets 25% Revenues From Reused, Recycled Products By 2025

share with twitter share with LinkedIn share with facebook
09/14/2020 | 05:49am EDT

By Maitane Sardon

 

Koninklijke Philips NV on Monday outlined new sustainability goals including its plan to increase revenue from low-waste activities to 25% of its sales by 2025.

The Dutch medical-technology company said over the next five years it will focus on reusing and recycling resources so a quarter of its sales come from circular products and services. In 2019 Philips generated 19.5 billion euros ($23 billion) in sales.

Philips said it will design all of its new products making sure these can be recycled or reused. To do so, the company said it will invest in sustainable innovation, extend its trade-in program to all its professional medical equipment and embed circular practices at its sites.

The company also said it will target 75% energy consumption from renewable sources by 2025, up from 36% in 2015.

Philips added it aims to have at least 30% of women in senior leadership roles by the end of 2025. Women currently make up almost a quarter of its senior management team, it said.

The company said it is on track to achieve its previous sustainability targets by the end of this year, including generating 70% of its sales from green products and services, having CO2-neutral operations and recycling 90% of its operational waste.

 

Write to Maitane Sardon at maitane.sardon@wsj.com

 


share with twitter share with LinkedIn share with facebook
All news about KONINKLIJKE PHILIPS N.V.
10/28KONINKLIJKE PHILIPS N : Philips introduces breakthrough Ultrasound 3300 system i..
AQ
10/28KONINKLIJKE PHILIPS N : Royal Philips - Philips introduces breakthrough Ultrasou..
AQ
10/28KONINKLIJKE PHILIPS N : Frans van Houten discusses Philips' transformation in FT..
PU
10/27KONINKLIJKE PHILIPS N : Philips to nominate Mrs. Indra Nooyi as member of the Su..
AQ
10/27KONINKLIJKE PHILIPS N : Philips empowers medical image access for over 5,000 cli..
AQ
10/26KONINKLIJKE PHILIPS N : Philips and Singapore General Hospital to establish Digi..
AQ
10/26KONINKLIJKE PHILIPS N : Philips empowers medical image access for over 5,000 cli..
AQ
10/26KONINKLIJKE PHILIPS N : Philips empowers medical image access for over 5,000 cli..
AQ
10/26Philips empowers medical image access for over 5,000 clinicians in the Region..
GL
10/26KONINKLIJKE PHILIPS N : Philips to nominate Mrs. Indra Nooyi as member of the Su..
AQ
More news
Financials
Sales 2020 19 621 M 22 953 M 22 953 M
Net income 2020 1 271 M 1 487 M 1 487 M
Net Debt 2020 3 335 M 3 902 M 3 902 M
P/E ratio 2020 29,1x
Yield 2020 2,09%
Capitalization 36 825 M 43 292 M 43 078 M
EV / Sales 2020 2,05x
EV / Sales 2021 1,98x
Nbr of Employees 80 718
Free-Float 99,7%
Chart KONINKLIJKE PHILIPS N.V.
Duration : Period :
Koninklijke Philips N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KONINKLIJKE PHILIPS N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Average target price 48,61 €
Last Close Price 40,49 €
Spread / Highest target 43,2%
Spread / Average Target 20,1%
Spread / Lowest Target -6,15%
EPS Revisions
Managers
NameTitle
Frans van Houten Chief Executive Officer
Jeroen van der Veer Chairman-Supervisory Board
Sophie Bechu Chief Operating Officer & Executive Vice President
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Jan Kimpen Chief Medical Officer
Sector and Competitors